Instituto de Investigación del Hospital de La Princesa-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Allergic inflammation triggers dyslipidemia via IgG signalling

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 10, pp. 2680-2699

  2. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry

    European Journal of Pediatrics, Vol. 183, Núm. 8, pp. 3567-3578

  3. Increased miR-21-3p levels in extracellular vesicles of children with food anaphylaxis

    Pediatric Allergy and Immunology

  4. PSGL-1, ADAM8, and selectins as potential biomarkers in the diagnostic process of systemic lupus erythematosus and systemic sclerosis: an observational study

    Frontiers in Immunology, Vol. 15

  5. Regulation of monocyte apoptosis and DNA extrusion in monocyte extracellular traps by PSGL-1: Relevance in systemic lupus erythematosus

    Translational Research, Vol. 274, pp. 10-20

  6. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry

    United European Gastroenterology Journal, Vol. 12, Núm. 5, pp. 585-595

2023

  1. Corrigendum to “Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry” [Digestive and Liver Disease Volume 55, Issue 3, March 2023, Pages 350–359] (Digestive and Liver Disease (2023) 55(3) (350–359), (S1590865822007289), (10.1016/j.dld.2022.09.020))

    Digestive and Liver Disease

  2. Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry

    Digestive and Liver Disease, Vol. 55, Núm. 3, pp. 350-359

2022

  1. Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice

    British Journal of Pharmacology, Vol. 179, Núm. 18, pp. 4534-4548

  2. The impact of type 2 immunity and allergic diseases in atherosclerosis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 11, pp. 3249-3266